Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.
Younossi ZM, de Avila L, Petta S, Hagström H, Kim SU, Nakajima A, Crespo J, Castera L, Alkhouri N, Zheng MH, Treeprasertsuk S, Ananchuensook P, Shalimar, Tsochatzis E, Trivikrama SK, Balakumaran LK, Fan JG, Roberts SK, Alswat K, Wai-Sun Wong V, Yilmaz Y, Dunn W, Francque S, Cordie A, Yu ML, Ekstedt M, Boon-Bee Goh G, Oliveira CP, Pessoa MG, Chan WK, Castellanos Fernandez MI, Duseja A, Arab JP, Papatheodoridis G, Sebastiani G, Villela-Nogueira C, D'Ambrosio R, Lampertico P, AlNaamani KM, Holleboom AG, Valsan A, Venu A, El-Kassas M, Pennisi G, Shang Y, Liu WY, Lee HW, Kobayashi T, Kakizaki S, Caussy C, Pearlman B, Iruzubieta P, Nadeem R, Cinque F, Neonaki A, Zoncapé M, Yang RX, Song SJ, Dunn N, Gadi Z, Yeh ML, Kim-Jun Teh K, Mahadeva S, Fabian LG, Almohsen A, Leite N, Pugliese N, Vessby J, Xie C, Choudhary NS, Friend E, Poca M, Kawaguchi T, Russo FP, Gadano A, Diaz LA, Singal AK, Segrestin B, Gunn N, Mauricio D, Arrese M, Fracanzani A, Lombardi R, Aghemo A, Lam B, Racila A, Alqahtani SA, Stepanova M; Global NASH/MASH Council (GNC).
Younossi ZM, et al. Among authors: nakajima a.
Clin Gastroenterol Hepatol. 2026 Jan 28:S1542-3565(26)00044-3. doi: 10.1016/j.cgh.2026.01.016. Online ahead of print.
Clin Gastroenterol Hepatol. 2026.
PMID: 41616900